Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Mar 10 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has received final approval from the USFDA for Ketoconazole Shampoo, a medication used to treat dandruff and fungal infections. The shampoo will be manufactured at the company's facility in Ahmedabad.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

In the deck

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases